BRAHMS* PCT Immunoassays by Thermo Fisher Scientific
Manufacturer Thermo Fisher Scientific
The Thermo Scientific* BRAHMS* PCT Immunoassays are immunofluorescent assays used to determine the concentration of PCT (procalcitonin) in human serum and plasma.
The Thermo Scientific* BRAHMS* PCT Immunoassays are intended for use in conjunction with other laboratory findings and clinical assessments to aid in the risk assessment of critically ill patients on their first day of ICU admission for progression to severe sepsis and septic shock.
The supplier does not provide quotations for this product through SelectScience. Browse these related products instead
Related Products
.jpg.ashx?width=100&height=100&bgcolor=white)
BRAHMS* PCT Immunoassays
The supplier does not provide quotations for this particular product through SelectScience. You can search for similar products in our product directory.
Average Rating: 4.7
2 Scientists have reviewed this product
Status:
Reviewer
Member since: 2017
Organization: Nexus DX
-
- Ease of use
- After sales service
- Value for money
This product very robust and easy for use. Gives results in 20 minutes.
Rating: 4.3
Application Area: Using for testing
"This device is easy to load with sample. There no need to prepare a sample prior usage. The sample spins, seperates to a needed amount and flows in the device itself while loaded into an analyzer."
Review date: 03 Aug 2017 | BRAHMS* PCT Immunoassays
Status:
Reviewer Member since: 2017
Organization: BioMed Diagnostic pte ltd
-
- Ease of use
- After sales service
- Value for money
Good product and marker
Rating: 5.0
Review date: 03 Aug 2017 | BRAHMS* PCT Immunoassays
Application Area:Sepsis diagnostic
"It a good marker to check the sepsis and a specific, it helps with early diagnosis"
Review date: 03 Aug 2017 | BRAHMS* PCT Immunoassays
The Thermo Scientific* BRAHMS* PCT Immunoassays are immunofluorescent assays used to determine the concentration of PCT (procalcitonin) in human serum and plasma.
The Thermo Scientific* BRAHMS* PCT Immunoassays are intended for use in conjunction with other laboratory findings and clinical assessments to aid in the risk assessment of critically ill patients on their first day of ICU admission for progression to severe sepsis and septic shock.
Product Overview
